Inattentional Blindness in Biology
Exceptional responders (ER) are those cancer "patients whom a complete or partial response was expected in less than 10% of similarly treated patients or whose duration of response lasted three times the published median or longer” (Wheeler et al. 2020). This represents a puzzling case for mainstream cancer research. The Tissue Organization Field Theory (TOFT) could instead explain it, by positing that the initiation and progression of cancer is due to the disruption of the normal interaction of cells and tissues, and that proliferation is the default state of all cells (Sonnenschein & Soto 2020). An increasing number of observations suggest that cancer initiation and its progression, or regression, are not primarily caused by intracellular processes but should be considered, instead, relational phenomena occurring in tissues, involving the entire organism and its environment.
Esteva de Sagrera J 2018, “Joaquín Balcells y Pasqual”, in Real Academia de la Historia, Diccionario Biográfico electrónico. Available from: http://dbe.rah.es/biografias/18541/joaquin-balcells-y-pasqual. [20 December 2020].
Pacini F 1866, “Microscopic observations and pathological deductions on Asiatic cholera”, The British and Foreign Medico-chirurgical Review, vol. 38, July. (English translation of “Osservazioni microscopiche e deduzioni patologiche sul cholera asiatico”, Gazzetta Medica Italiana: Toscana, 2nd series, vol. 4, no. 50, pp. 397–401 and vol. 4, no. 51, pp. 405–412. Available from: https://books.google.com/books?id=PXw6AQAAMAAJ&pg=PA167. [20 December 2010].
Simons DJ & Chabris CF 1999, “Gorillas in our midst: Sustained inattentional blindness for dynamic events”, Perception, vol. 28, no. 9, pp. 1059–74. Available from: doi: 10.1068/p281059. [20 December 2010].
Sonnenschein C & Soto AM 2020, “Over a century of cancer research: Inconvenient truths and promising leads”, PLoS Biol, vol. 18, no. 4: e3000670. Available from: doi: 10.1371/journal.pbio.3000670.
Wheeler DA et al. 2020, “Molecular features of cancers exhibiting exceptional responses to treatment”, Cancer Cell, November 16, In press, Corrected proof, Nov 16:S1535-6108(20)30546-8. Available from: doi: 10.1016/j.ccell.2020.10.015. Epub ahead of print. PMID: 33217343.
How to Cite
Copyright Agreement with Authors
Before publication, after the acceptance of the manuscript, authors have to sign a Publication Agreement with Organisms. The authors retain all rights to the original work without any restrictions.
License for Published Contents
You are free to copy, distribute and transmit the work, and to adapt the work. You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work).